Vnitr Lek 2022, 68(3):144-153 | DOI: 10.36290/vnl.2022.030

Telemedicine in diabetology

Robert Bém
Centrum diabetologie, Institut klinické a experimentální medicíny, Praha

The basis of telemedicine is the use of modern technologies that are used in everyday life, but also in diabetes management. Technology are applied not only in insulin administration and glycemic monitoring, but also in the management of lifestyle interventions such as healthy eating and physical activity. Telemedicine in diabetes can significantly expand our options for the care of patients with diabetes and its complications, leading to convincing improvements in diabetes control and self-management of patients with diabetes. The positive effect of telemedicine depends on the correct setup of data transmission and processing, but also on the education of all involved. Telemedicine promotes the involvement of patients as well as other healthcare professionals in diabetes management, improves care coordination and streamlines communication between patients and healthcare professionals.

Keywords: diabetes mellitus, technology, telemedicine, glucose monitoring, artificial intelligence.

Published: April 26, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bém R. Telemedicine in diabetology. Vnitr Lek. 2022;68(3):144-153. doi: 10.36290/vnl.2022.030.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396(10267):2019-82. Go to original source... Go to PubMed...
    2. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available from: https://www.diabetesatlas.org
    3. Borries TM, Dunbar A, Bhukhen A, Rismany J, Kilham J, Feinn R et al. The impact of telemedicine on patient self‑management processes and clinical outcomes for patients with Types I or II Diabetes Mellitus in the United States: A scoping review. Diabetes Metab Syndr. 2019;13(2):1353-7. Go to original source... Go to PubMed...
    4. McDonnell ME. Telemedicine in Complex Diabetes Management. Curr Diab Rep. 2018;18(7):42. Go to original source... Go to PubMed...
    5. Shan R, Sarkar S, Martin SS. Digital health technology and mobile devices for the management of diabetes mellitus: state of the art. Diabetologia. 2019;62(6):877-87. Go to original source... Go to PubMed...
    6. Hanlon P, Daines L, Campbell C, McKinstry B, Weller D, Pinnock H. Telehealth Interventions to Support Self‑Management of Long‑Term Conditions: A Systematic Metareview of Diabetes, Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, and Cancer. J Med Internet Res. 2017;19(5):e172. Go to original source... Go to PubMed...
    7. Fagherazzi G, Ravaud P. Digital diabetes: Perspectives for diabetes prevention, management and research. Diabetes Metab. 2019;45(4):322-9. Go to original source... Go to PubMed...
    8. Andres E, Meyer L, Zulfiqar AA, Hajjam M, Talha S, Bahougne T et al. Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies. J Med Life. 2019;12(3):203-14. Go to original source... Go to PubMed...
    9. Greenwood DA, Gee PM, Fatkin KJ, Peeple MA. Systematic Review of Reviews Evaluating Technology‑Enabled Diabetes Self‑Management Education and Support. J Diabetes Sci Technol. 2017;11(5):1015-27. Go to original source... Go to PubMed...
    10. Garg S, Norman GJ. Impact of COVID-19 on Health Economics and Technology of Diabetes Care: Use Cases of Real‑Time Continuous Glucose Monitoring to Transform Health Care During a Global Pandemic. Diabetes Technol Ther. 2021;23(S1):S15-S20. Go to original source... Go to PubMed...
    11. Nguyen OT, Alishahi Tabriz A, Huo J, Hanna K, Shea CM, Turner K. Impact of Asynchronous Electronic Communication‑Based Visits on Clinical Outcomes and Health Care Delivery: Systematic Review. J Med Internet Res. 2021;23(5):e27531. Go to original source... Go to PubMed...
    12. Heinemann L, Schnell O, Gehr B, Schloot NC, Gorgens SW, Gorgen C. Digital Diabetes Management: A Literature Review of Smart Insulin Pens. J Diabetes Sci Technol. 2021:1932296820983863. Go to original source... Go to PubMed...
    13. Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Res Clin Pract. 2017;133:178-92. Go to original source... Go to PubMed...
    14. Wood A, O'Neal D, Furler J, Ekinci EI. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. Intern Med J. 2018;48(5):499-508. Go to original source... Go to PubMed...
    15. Ang E, Lee ZX, Moore S, Nana M. Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life. J Diabetes Complications. 2020;34(6):107559. Go to original source... Go to PubMed...
    16. Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Glycaemic management in diabetes: old and new approaches. Lancet Diabetes Endocrinol. 2022;10(1):75-84. Go to original source... Go to PubMed...
    17. Eberle C, Stichling S. Telemetric Interventions Offer New Opportunities for Managing Type 1 Diabetes Mellitus: Systematic Meta‑review. JMIR Diabetes. 2021;6(1):e20270. Go to original source... Go to PubMed...
    18. Boughton CK, Hovorka R. New closed‑loop insulin systems. Diabetologia. 2021;64(5):1007-15. Go to original source... Go to PubMed...
    19. Eberle C, Lohnert M, Stichling S. Effectiveness of Disease‑Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review. JMIR Mhealth Uhealth. 2021;9(2):e23477. Go to original source... Go to PubMed...
    20. Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta‑Analyses. J Med Internet Res. 2020;22(3):e16791. Go to original source... Go to PubMed...
    21. Zhang B. Expert Consensus on Telemedicine Management of Diabetes (2020 Edition). Int J Endocrinol. 2021;2021:6643491. Go to original source... Go to PubMed...
    22. Eze ND, Mateus C, Cravo Oliveira Hashiguchi T. Telemedicine in the OECD: An umbrella review of clinical and cost‑effectiveness, patient experience and implementation. PLoS One. 2020;15(8):e0237585. Go to original source... Go to PubMed...
    23. Eberle C, Stichling S. Effects of Telemetric Interventions on Maternal and Fetal or Neonatal Outcomes in Gestational Diabetes: Systematic Meta‑Review. JMIR Diabetes. 2021;6(3):e24284. Go to original source... Go to PubMed...
    24. Eberle C, Stichling S. Effect of Telemetric Interventions on Glycated Hemoglobin A1c and Management of Type 2 Diabetes Mellitus: Systematic Meta‑Review. J Med Internet Res. 2021;23(2):e23252. Go to original source... Go to PubMed...
    25. Hu Y, Wen X, Wang F, Yang D, Liu S, Li P et al. Effect of telemedicine intervention on hypoglycaemia in diabetes patients: A systematic review and meta‑analysis of randomised controlled trials. J Telemed Telecare. 2019;25(7):402-13. Go to original source... Go to PubMed...
    26. Snorgaard O, Poulsen GM, Andersen HK, Astrup A. Systematic review and meta‑analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000354. Go to original source... Go to PubMed...
    27. Pai LW, Li TC, Hwu YJ, Chang SC, Chen LL, Chang PY. The effectiveness of regular leisure‑time physical activities on long‑term glycemic control in people with type 2 diabetes: A systematic review and meta‑analysis. Diabetes Res Clin Pract. 2016;113:77-85. Go to original source... Go to PubMed...
    28. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC. The effect of oral antidiabetic agents on A1C levels: a systematic review and meta‑analysis. Diabetes Care. 2010;33(8):1859-64. Go to original source... Go to PubMed...
    29. Effect of intensive blood‑glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854-65. Go to original source...
    30. Danne T, Limbert C, Puig Domingo M, Del Prato S, Renard E, Choudhary P et al. Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post‑COVID Future. Diabetes Ther. 2021;12(9):2289-310. Go to original source... Go to PubMed...
    31. Yaron M, Sher B, Sorek D, Shomer M, Levek N, Schiller T et al. A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps. Acta Diabetol. 2019;56(6):667-73. Go to original source... Go to PubMed...
    32. Schlesinger S, Neuenschwander M, Barbaresko J, Lang A, Maalmi H, Rathmann W et al. Prediabetes and risk of mortality, diabetes‑related complications and comorbidities: umbrella review of meta‑analyses of prospective studies. Diabetologia. 2022;65(2):275-85. Go to original source... Go to PubMed...
    33. Mishra K, Edwards B. Cardiac Outpatient Care in a Digital Age: Remote Cardiology Clinic Visits in the Era of COVID-19. Curr Cardiol Rep. 2022. Go to original source...
    34. Li JO, Liu H, Ting DSJ, Jeon S, Chan RVP, Kim JE et al. Digital technology, tele‑medicine and artificial intelligence in ophthalmology: A global perspective. Prog Retin Eye Res. 2021;82:100900. Go to original source... Go to PubMed...
    35. Chen L, Cheng L, Gao W, Chen D, Wang C, Ran X. Telemedicine in Chronic Wound Management: Systematic Review And Meta‑Analysis. JMIR Mhealth Uhealth. 2020;8(6):e15574. Go to original source... Go to PubMed...
    36. Olivia NU, Happiness UC, Obinna OM. Protective effect of Cnidoscolus aconitifolius leaves against diclofenac‑induced gastric mucosal damage. Pak J Pharm Sci. 2020;33(2):651-7.
    37. Tchero H, Noubou L, Becsangele B, Mukisi‑Mukaza M, Retali GR, Rusch E. Telemedicine in Diabetic Foot Care: A Systematic Literature Review of Interventions and Meta‑analysis of Controlled Trials. Int J Low Extrem Wounds. 2017;16(4):274-83. Go to original source... Go to PubMed...
    38. Lipscomb D, Smith AS, Adamson S, Rezazadeh EM. Diabetic foot ulceration in COVID-19 lockdown: cause for concern or unexpected benefit? Diabet Med. 2020;37(8):1409-10. Go to original source... Go to PubMed...
    39. Fasterholdt I, Gerstrom M, Rasmussen BSB, Yderstraede KB, Kidholm K, Pedersen KM. Cost‑effectiveness of telemonitoring of diabetic foot ulcer patients. Health Informatics J. 2018;24(3):245-58. Go to original source... Go to PubMed...
    40. Appuswamy AV, Desimone ME. Managing Diabetes in Hard to Reach Populations: A Review of Telehealth Interventions. Curr Diab Rep. 2020;20(7):28. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.